Systemic chemotherapy with trastuzumab and paclitaxel has been found to be effective in metastatic EMPD, where the overexpression of human epidermal growth factor receptor 2 protein leads to deep dermal invasion and metastatic spread of the tumor [6]. The gene discussed is ERBB2; the disease is neoplasm.